scholarly article | Q13442814 |
P2093 | author name string | Cui-Cui Li | |
Xiao-Jia Wang | |||
P2860 | cites work | The Coronavirus Spike Protein Is a Class I Virus Fusion Protein: Structural and Functional Characterization of the Fusion Core Complex | Q27477706 |
Structure of the Fusion Core and Inhibition of Fusion by a Heptad Repeat Peptide Derived from the S Protein of Middle East Respiratory Syndrome Coronavirus | Q27680061 | ||
Nucleocapsid Interacts with NPM1 and Protects it from Proteolytic Cleavage, Enhancing Cell Survival, and is Involved in PEDV Growth | Q28357295 | ||
Mechanisms of viral membrane fusion and its inhibition | Q29616090 | ||
Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines | Q34030358 | ||
Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells | Q35123537 | ||
Hydroxychloroquine-inhibited dengue virus is associated with host defense machinery | Q35148912 | ||
RNA interference and antiviral therapy. | Q36944914 | ||
A cholesterol tag at the N terminus of the relatively broad-spectrum fusion inhibitory peptide targets an earlier stage of fusion glycoprotein activation and increases the peptide's antiviral potency in vivo | Q37123271 | ||
Detailed mechanistic insights into HIV-1 sensitivity to three generations of fusion inhibitors | Q37446872 | ||
HIV-1 gp41 fusion intermediate: a target for HIV therapeutics | Q37703732 | ||
Porcine Epidemic Diarrhea Virus Induces Autophagy to Benefit Its Replication | Q37727847 | ||
Future directions for peptide therapeutics development | Q38111100 | ||
Taming Influenza Virus: Role of Antisense Technology | Q38540083 | ||
Antiviral strategies combining antiretroviral drugs with RNAi-mediated attack on HIV-1 and cellular co-factors | Q39188929 | ||
Adenovirus-vectored shRNAs targeted to the highly conserved regions of VP1 and 2B in tandem inhibits replication of foot-and-mouth disease virus both in vitro and in vivo | Q39397779 | ||
Inhibition of chicken anaemia virus replication using multiple short-hairpin RNAs. | Q39964715 | ||
Electrostatically constrained alpha-helical peptide inhibits replication of HIV-1 resistant to enfuvirtide | Q40039248 | ||
Silencing of HIV-1 with RNA interference: a multiple shRNA approach | Q40234514 | ||
Cellular protein GLTSCR2: A valuable target for the development of broad-spectrum antivirals. | Q40295640 | ||
Ribavirin and interferon-beta synergistically inhibit SARS-associated coronavirus replication in animal and human cell lines. | Q40479393 | ||
Effective inhibition of porcine epidemic diarrhea virus by RNA interference in vitro | Q41020916 | ||
Isolation and characterization of a variant porcine epidemic diarrhea virus in China | Q41525790 | ||
Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice | Q41751679 | ||
Cloning and sequence analysis of the M gene of porcine epidemic diarrhea virus LJB/03. | Q42649236 | ||
RNA interference inhibits replication of tick-borne encephalitis virus in vitro | Q43042424 | ||
Outbreak of porcine epidemic diarrhea in suckling piglets, China | Q43204039 | ||
Inhibition of SARS-CoV replication by siRNA. | Q45206542 | ||
Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies. | Q45323822 | ||
Down-regulation of gene expression by RNA-induced gene silencing | Q46246567 | ||
Targeting of phospho-eIF4E by homoharringtonine eradicates a distinct subset of human acute myeloid leukemia. | Q50046142 | ||
Hydroxychloroquine attenuates renal ischemia/reperfusion injury by inhibiting cathepsin mediated NLRP3 inflammasome activation. | Q52676433 | ||
Characterisation and evaluation of antiviral recombinant peptides based on the heptad repeat regions of NDV and IBV fusion glycoproteins | Q56770003 | ||
The Natural Compound Homoharringtonine Presents Broad Antiviral Activity In Vitro and In Vivo | Q58580106 | ||
Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection | Q59355480 | ||
Hydroxychloroquine Inhibits Zika Virus NS2B-NS3 Protease | Q60487632 | ||
Inhibition of porcine transmissible gastroenteritis virus (TGEV) replication in mini-pigs by shRNA | Q82539958 | ||
Patisiran: First Global Approval | Q91712937 | ||
P433 | issue | 1 | |
P921 | main subject | hydroxychloroquine | Q421094 |
Coronaviridae | Q1134583 | ||
P304 | page(s) | 71 | |
P577 | publication date | 2020-06-03 | |
P1433 | published in | Virology Journal | Q7934868 |
P1476 | title | Three kinds of treatment with Homoharringtonine, Hydroxychloroquine or shRNA and their combination against coronavirus PEDV in vitro | |
P478 | volume | 17 |
Q98568491 | On-target versus off-target effects of drugs inhibiting the replication of SARS-CoV-2 | cites work | P2860 |
Search more.